Dean Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,088
| Closed | -$669K | – | 141 |
|
|
2024
Q2 | $669K | Buy |
8,088
+614
| +8% | +$50.8K | 0.86% | 51 |
|
|
2024
Q1 | $638K | Buy |
7,474
+3,766
| +102% | +$321K | 0.37% | 114 |
|
|
2023
Q4 | $317K | Sell |
3,708
-851
| -19% | -$72.8K | 0.2% | 119 |
|
|
2023
Q3 | $408K | Sell |
4,559
-573
| -11% | -$51.3K | 0.31% | 115 |
|
|
2023
Q2 | $437K | Buy |
5,132
+2,265
| +79% | +$193K | 0.58% | 68 |
|
|
2023
Q1 | $237K | Sell |
2,867
-302
| -10% | -$25K | 0.31% | 67 |
|
|
2022
Q4 | $249K | Sell |
3,169
-14
| -0.4% | -$1.1K | 0.33% | 68 |
|
|
2022
Q3 | $236K | Sell |
3,183
-2,008
| -39% | -$149K | 0.35% | 66 |
|
|
2022
Q2 | $338K | Sell |
5,191
-3,328
| -39% | -$217K | 0.3% | 72 |
|
|
2022
Q1 | $539K | Sell |
8,519
-6,790
| -44% | -$430K | 0.47% | 63 |
|
|
2021
Q4 | $812K | Buy |
15,309
+2,982
| +24% | +$158K | 0.7% | 54 |
|
|
2021
Q3 | $870K | Sell |
12,327
-1,364
| -10% | -$96.3K | 0.8% | 51 |
|
|
2021
Q2 | $912K | Buy |
+13,691
| New | +$912K | 0.84% | 53 |
|
|
2014
Q4 | – | Sell |
-2,235
| Closed | -$78K | – | 82 |
|
|
2014
Q3 | $78K | Sell |
2,235
-300
| -12% | -$10.5K | 1.07% | 44 |
|
|
2014
Q2 | $90K | Buy |
+2,535
| New | +$90K | 1% | 55 |
|